Latest Funding Agreements News

Emyria Limited reports a reduced net loss of $3.14 million for FY2025, driven by strategic expansion in psychedelic-assisted mental health treatments and key partnerships including insurer Medibank. The company advances clinical services while continuing R&D on proprietary medicines.

Ramsay Health Care reported a modest 1.7% increase in underlying net profit for FY25, driven by strong Australian and UK hospital performances despite significant impairments in the UK. The company is advancing its multi-year transformation and expects EBIT growth in Australia for FY26, though challenges remain.

Ark Mines has landed a $4.5 million investment from Queensland’s Critical Minerals and Battery Technology Fund, accelerating development at its Sandy Mitchell rare earths project with production targeted for late 2027.

NOVONIX Limited reports progress scaling its Chattanooga synthetic graphite plant, secures major funding, and benefits from U.S. tariffs on Chinese imports, while narrowing its half-year loss.

BrainChip Holdings reports a significant revenue surge and reduced losses in H1 2025, underpinned by new contracts, strategic collaborations, and an expanded funding agreement.

Adelong Gold Limited has formally declared a deadlock in its joint venture with Great Divide Mining, prompting a dispute resolution process as both parties contest the status of their collaboration.

Opthea Limited has terminated its sozinibercept wet AMD program following Phase 3 trial failures and settled a major funding agreement, setting the stage for a strategic reset.

Opthea has successfully settled its Development Funding Agreement, avoiding a potential $680 million liability and securing $20 million in cash. Leadership changes include the CEO and CFO stepping down, with the Chairman assuming CEO duties.

Great Divide Mining disputes the validity of a Deadlock Notice issued by Adelong Gold over their Challenger Gold Mine joint venture, asserting the annual plan was properly approved and no deadlock exists.

EQ Resources has finalized a US$7.5 million royalty funding agreement with Oaktree Capital Management to support its Barruecopardo tungsten project, while major shareholder Cronimet Asia converts a US$3 million offtake prepayment into equity, strengthening the company’s capital position.

AnteoTech has mutually terminated its A$1.4 million Queensland government grant to avoid costly co-investment, opting instead for cheaper third-party testing to advance its Ultranode™ battery technology.

Brisbane Broncos Limited projects a net profit before tax of $8.69 million for H1 2025, up from $6.30 million a year earlier, driven by an additional NRL home game and stronger revenues across ticketing, sponsorship, and merchandise.